• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光遗传学淀粉样蛋白-β在神经退行性变中区分代谢和物理损伤的应用。

Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.

机构信息

Science Division, Yale- NUS College, Singapore, Singapore.

Institute of Molecular and Cell Biology (IMCB), Singapore, Singapore.

出版信息

Elife. 2020 Mar 31;9:e52589. doi: 10.7554/eLife.52589.

DOI:10.7554/eLife.52589
PMID:32228858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7145416/
Abstract

The brains of Alzheimer's disease patients show a decrease in brain mass and a preponderance of extracellular Amyloid-β plaques. These plaques are formed by aggregation of polypeptides that are derived from the Amyloid Precursor Protein (APP). Amyloid-β plaques are thought to play either a direct or an indirect role in disease progression, however the exact role of aggregation and plaque formation in the aetiology of Alzheimer's disease (AD) is subject to debate as the biological effects of soluble and aggregated Amyloid-β peptides are difficult to separate in vivo. To investigate the consequences of formation of Amyloid-β oligomers in living tissues, we developed a fluorescently tagged, optogenetic Amyloid-β peptide that oligomerizes rapidly in the presence of blue light. We applied this system to the crucial question of how intracellular Amyloid-β oligomers underlie the pathologies of A. We use , and to show that, although both expression and induced oligomerization of Amyloid-β were detrimental to lifespan and healthspan, we were able to separate the metabolic and physical damage caused by light-induced Amyloid-β oligomerization from Amyloid-β expression alone. The physical damage caused by Amyloid-β oligomers also recapitulated the catastrophic tissue loss that is a hallmark of late AD. We show that the lifespan deficit induced by Amyloid-β oligomers was reduced with Li treatment. Our results present the first model to separate different aspects of disease progression.

摘要

阿尔茨海默病患者的大脑表现出脑质量下降和细胞外淀粉样β斑块增多。这些斑块是由淀粉样前体蛋白(APP)衍生的多肽聚集形成的。淀粉样β斑块被认为在疾病进展中发挥直接或间接作用,然而,淀粉样β肽聚集和斑块形成在阿尔茨海默病(AD)发病机制中的确切作用仍存在争议,因为可溶性和聚集的淀粉样β肽的生物学效应在体内难以分离。为了研究淀粉样β低聚物在活组织中的形成后果,我们开发了一种荧光标记的光遗传淀粉样β肽,在蓝光存在下迅速聚集。我们将该系统应用于一个关键问题,即细胞内淀粉样β低聚物如何构成 A 的病理学基础。我们使用 、 和 表明,尽管淀粉样β的表达和诱导寡聚化对寿命和健康寿命都有不利影响,但我们能够将光诱导的淀粉样β寡聚化引起的代谢和物理损伤与淀粉样β单独表达引起的损伤区分开来。淀粉样β低聚物引起的物理损伤也再现了 AD 晚期的组织大量丢失这一标志性特征。我们表明,用 Li 处理可降低淀粉样β低聚物诱导的寿命缺陷。我们的结果提出了第一个能够分离疾病进展不同方面的模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/a97eb5597151/elife-52589-fig8-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/ad461dd703de/elife-52589-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/4ab2ca47ffd7/elife-52589-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/b4f5fca73821/elife-52589-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/4fc72d22d95a/elife-52589-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/5fe97a458d90/elife-52589-fig1-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/5fa705a9eb50/elife-52589-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/755363678e61/elife-52589-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/7b6ae0fc2288/elife-52589-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/2366c0cb026c/elife-52589-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/a3b0a7ded22a/elife-52589-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/117e0da77aaa/elife-52589-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/83eac1a0d0b5/elife-52589-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/26ec7106ab86/elife-52589-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/a62bb33ba148/elife-52589-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/a97eb5597151/elife-52589-fig8-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/ad461dd703de/elife-52589-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/4ab2ca47ffd7/elife-52589-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/b4f5fca73821/elife-52589-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/4fc72d22d95a/elife-52589-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/5fe97a458d90/elife-52589-fig1-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/5fa705a9eb50/elife-52589-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/755363678e61/elife-52589-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/7b6ae0fc2288/elife-52589-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/2366c0cb026c/elife-52589-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/a3b0a7ded22a/elife-52589-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/117e0da77aaa/elife-52589-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/83eac1a0d0b5/elife-52589-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/26ec7106ab86/elife-52589-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/a62bb33ba148/elife-52589-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60f8/7145416/a97eb5597151/elife-52589-fig8-figsupp1.jpg

相似文献

1
Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.光遗传学淀粉样蛋白-β在神经退行性变中区分代谢和物理损伤的应用。
Elife. 2020 Mar 31;9:e52589. doi: 10.7554/eLife.52589.
2
Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.纤维状 Aβ 在阿尔茨海默病小鼠模型中引发小胶质细胞蛋白质组改变和功能障碍。
Elife. 2020 Jun 8;9:e54083. doi: 10.7554/eLife.54083.
3
Use of Optogenetic Amyloid-β to Monitor Protein Aggregation in and .使用光遗传学淀粉样蛋白-β来监测[具体生物或组织]中的蛋白质聚集。 (注:原文中“in and.”表述不完整,推测可能是在特定生物或组织中,但此处根据已有原文只能这样模糊翻译)
Bio Protoc. 2020 Dec 5;10(23):e3856. doi: 10.21769/BioProtoc.3856.
4
Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease.非典型可溶性淀粉样β聚集体与斑块缓冲:阿尔茨海默病靶点发现的争议与未来方向
Alzheimers Res Ther. 2017 Aug 17;9(1):62. doi: 10.1186/s13195-017-0293-3.
5
The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations.淀粉样β纤维核形成的遗传景观能准确地区分家族性阿尔茨海默病突变。
Elife. 2021 Feb 1;10:e63364. doi: 10.7554/eLife.63364.
6
Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.人脑中淀粉样β肽聚集和积累的生化阶段及其与症状前和病理前阿尔茨海默病的关系。
Brain. 2014 Mar;137(Pt 3):887-903. doi: 10.1093/brain/awt362. Epub 2014 Feb 10.
7
A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.阿尔茨海默病的病理生理学和治疗干预的最新进展。
Curr Pharm Des. 2023;29(43):3428-3441. doi: 10.2174/0113816128264355231121064704.
8
Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.阐明淀粉样寡聚体的结构与大环 β-发夹肽:对阿尔茨海默病和其他淀粉样疾病的启示。
Acc Chem Res. 2018 Mar 20;51(3):706-718. doi: 10.1021/acs.accounts.7b00554. Epub 2018 Mar 6.
9
Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.利用多模态 MALDI 成像质谱法揭示转基因阿尔茨海默病小鼠中淀粉样斑块的分子病理学。
ACS Chem Neurosci. 2018 Jul 18;9(7):1802-1817. doi: 10.1021/acschemneuro.8b00121. Epub 2018 May 4.
10
Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.无淀粉样蛋白斑块病理的β 淀粉样蛋白二聚体损害学习和突触可塑性。
Brain. 2016 Feb;139(Pt 2):509-25. doi: 10.1093/brain/awv355. Epub 2015 Dec 10.

引用本文的文献

1
Combining light-induced aggregation and biotin proximity labeling implicates endolysosomal proteins in early α-synuclein oligomerization.结合光诱导聚集和生物素邻近标记表明内溶酶体蛋白参与早期α-突触核蛋白寡聚化。
iScience. 2025 Jun 6;28(7):112823. doi: 10.1016/j.isci.2025.112823. eCollection 2025 Jul 18.
2
Optogenetics to biomolecular phase separation in neurodegenerative diseases.神经退行性疾病中的光遗传学与生物分子相分离
Mol Cells. 2025 Aug;48(8):100247. doi: 10.1016/j.mocell.2025.100247. Epub 2025 Jun 22.
3
Modeling Alzheimer's Disease: A Review of Gene-Modified and Induced Animal Models, Complex Cell Culture Models, and Computational Modeling.

本文引用的文献

1
Drug synergy as a strategy for compression of morbidity in a Caenorhabditis elegans model of Alzheimer's disease.药物协同作用作为一种策略,用于压缩阿尔茨海默病的秀丽隐杆线虫模型中的发病。
Geroscience. 2020 Jun;42(3):849-856. doi: 10.1007/s11357-020-00169-1. Epub 2020 Feb 22.
2
Metabolic stress is a primary pathogenic event in transgenic expressing pan-neuronal human amyloid beta.代谢应激是表达泛神经元人淀粉样β的转基因中主要的致病事件。
Elife. 2019 Oct 15;8:e50069. doi: 10.7554/eLife.50069.
3
Molecular Mechanisms of Lithium Action: Switching the Light on Multiple Targets for Dementia Using Animal Models.
阿尔茨海默病建模:基因修饰和诱导动物模型、复杂细胞培养模型及计算建模综述
Brain Sci. 2025 May 5;15(5):486. doi: 10.3390/brainsci15050486.
4
Studying the mechanisms of neurodegeneration: advantages and opportunities.研究神经退行性变的机制:优势与机遇。
Front Cell Neurosci. 2025 Mar 26;19:1559151. doi: 10.3389/fncel.2025.1559151. eCollection 2025.
5
Live-cell visualization of tau aggregation in human neurons.人神经元中 tau 聚集的活细胞可视化。
Commun Biol. 2024 Sep 14;7(1):1143. doi: 10.1038/s42003-024-06840-z.
6
Application of Optogenetics in Neurodegenerative Diseases.光遗传学在神经退行性疾病中的应用。
Cell Mol Neurobiol. 2024 Jul 26;44(1):57. doi: 10.1007/s10571-024-01486-1.
7
Evaluating the inter-species transmission risk of amyloid beta peptide aggregates via ingestion.评估通过摄入方式导致淀粉样 β 肽聚集物在物种间传播的风险。
Alzheimers Res Ther. 2024 Jun 7;16(1):123. doi: 10.1186/s13195-024-01487-8.
8
The Wnt Co-Receptor PTK7/Otk and Its Homolog Otk-2 in Neurogenesis and Patterning.Wnt 共受体 PTK7/Otk 及其同源物 Otk-2 在神经发生和模式形成中的作用
Cells. 2024 Feb 20;13(5):365. doi: 10.3390/cells13050365.
9
Simple models to understand complex disease: 10 years of progress from models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.理解复杂疾病的简单模型:从肌萎缩侧索硬化症和额颞叶痴呆模型取得的十年进展
Front Neurosci. 2024 Jan 4;17:1300705. doi: 10.3389/fnins.2023.1300705. eCollection 2023.
10
Optogenetics in Alzheimer's Disease: Focus on Astrocytes.阿尔茨海默病中的光遗传学:聚焦于星形胶质细胞。
Antioxidants (Basel). 2023 Oct 13;12(10):1856. doi: 10.3390/antiox12101856.
锂作用的分子机制:利用动物模型揭示痴呆症的多个靶点
Front Mol Neurosci. 2018 Aug 28;11:297. doi: 10.3389/fnmol.2018.00297. eCollection 2018.
4
Cancer mutations and targeted drugs can disrupt dynamic signal encoding by the Ras-Erk pathway.癌症突变和靶向药物可以破坏 Ras-Erk 通路的动态信号编码。
Science. 2018 Aug 31;361(6405). doi: 10.1126/science.aao3048.
5
Alzheimer's disease drug development pipeline: 2018.2018年阿尔茨海默病药物研发进展
Alzheimers Dement (N Y). 2018 May 3;4:195-214. doi: 10.1016/j.trci.2018.03.009. eCollection 2018.
6
A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease.一种用于模拟阿尔茨海默病中神经退行性变和神经炎症的 3D 人三细胞培养系统。
Nat Neurosci. 2018 Jul;21(7):941-951. doi: 10.1038/s41593-018-0175-4. Epub 2018 Jun 27.
7
Longevity extension in Drosophila through gut-brain communication.通过肠脑通讯延长果蝇寿命。
Sci Rep. 2018 May 30;8(1):8362. doi: 10.1038/s41598-018-25382-z.
8
Modeling Alzheimer's and Other Age Related Human Diseases in Embryonic Systems.在胚胎系统中模拟阿尔茨海默病及其他与年龄相关的人类疾病
J Dev Biol. 2017 Dec 22;6(1):1. doi: 10.3390/jdb6010001.
9
Alzheimer's Disease, Oligomers, and Inflammation.阿尔茨海默病、寡聚物与炎症
J Alzheimers Dis. 2018;62(3):1261-1276. doi: 10.3233/JAD-170819.
10
Amyloid β oligomers (AβOs) in Alzheimer's disease.阿尔茨海默病中的淀粉样β寡聚物(AβOs)。
J Neural Transm (Vienna). 2018 Feb;125(2):177-191. doi: 10.1007/s00702-017-1820-x. Epub 2017 Dec 1.